GlassScriptPhysician profile
Nat T Levy
NPI 1790777225
$907.24
in general payments reported to CMS, 2019-2025
14 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $84.34 · 2021: $194 · 2022: $239 · 2023: $37.73 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $181 · Food and Beverage: $37.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $180.98 |
| Food and Beverage | $37.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $209.26 | 2019-2023 | Arexvy |
| Harmony Biosciences LLC | $206.02 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $92.99 | 2025 | |
| Pulmonx Corporation | $88.00 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $51.84 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.22 | 2019-2020 | |
| Mylan Specialty L.P. | $42.63 | 2019-2021 | |
| Philips North America LLC | $34.50 | 2022 | |
| Grifols USA, LLC | $28.73 | 2022 | |
| Horizon Therapeutics Plc | $26.72 | 2020 | |
| Inspire Medical Systems, INC. | $23.99 | 2023 | Inspire |
| Genentech USA, INC. | $22.60 | 2019 | |
| Genzyme Corporation | $14.58 | 2021 | |
| Insmed, INC. | $14.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nat Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.